v3 Template
P

Phathom Pharmaceuticals Inc.

Biopharmaceutical / Healthcare FLORHAM PARK, N.J. ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$841.0M
Funding Rounds
5
Last Funding
2026-01-07

About Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment landscape for acid-related gastrointestinal (GI) disorders, aiming to improve the lives of patients by advancing innovative treatments.

Products & Services

VOQUEZNA (vonoprazan):A prescription medicine for adults used to heal acid-related damage to the esophagus (Erosive Esophagitis) for 8 weeks, maintain healing of Erosive Esophagitis for up to 6 months, and provide relief of heartburn related to gastroesophageal reflux disease (GERD) for 4 weeks.

Specialties

Acid-related gastrointestinal disorders Treatment of Erosive Esophagitis Treatment of GERD (Gastroesophageal Reflux Disease) Innovative therapeutics development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 130000000
MR: -
FA: approximately $130 million
FAN: 130000000
D: 2026-01-07
FD: 2026-01-07
6 investors
2 RT: Equity Offering
T: -
FT: Equity Offering
A: 130000000
MR: -
FA: $130 million
FAN: 130000000
D: 2024-08-19
FD: 2024-08-19
6 investors
3 RT: Debt
T: -
FT: Debt
A: 300000000
MR: -
FA: Up to $300 million
FAN: 300000000
D: 2023-12-14
FD: 2023-12-14
2 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 150300000
MR: -
FA: approximately $150.3 million
FAN: 150300000
D: 2023-06-09
FD: 2023-06-09
3 investors
5 RT: Public Offering
T: -
FT: Public Offering
A: 130700000
MR: -
FA: approximately $130.7 million
FAN: 130700000
D: 2023-05-23
FD: 2023-05-23
3 investors
Public Offering Latest
2026-01-07
$130.0M
6 investors (Pro only)
Equity Offering 2024-08-19
$130.0M
Debt 2023-12-14
$300.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Steven Basta

President & Chief Executive Officer

A

Anne Marie Cook

Chief Legal Officer and Corporate Secretary

P

Paul Cocja

Chief People Officer

E

Eckhard Leifke

Chief Medical Officer

B

Bill Aprea

Senior Vice President, Chief Compliance Officer and Deputy Chief Legal Officer

J

Jonathan Bentley

Senior Vice President, Head of Sales, Operations, & Training

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Phathom Pharmaceuticals Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical / Healthcare
Company Size
~420 employees (est.)
Locations
FLORHAM PARK, N.J.
Florham Park, N.J.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro